The Patient as Your Guide: Thriving in New Commercial Models
The pharmaceutical industry is undergoing significant disruption, requiring a shift to new commercial models. Key factors include the complexity of specialty and rare-disease treatments, the rise of consumer-driven healthcare, new post-pandemic health delivery models, and policy changes affecting access and affordability.